Full-Time

Senior Production Associate

Posted on 5/9/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Melbourne VIC, Australia

In Person

Category
Operations & Logistics (1)
Requirements
  • Previous industry experience and/or Bachelor of Science, Pharmacy or related Discipline
  • Excellent written and verbal skills with good attention to detail
  • Documented cGMP training
  • Previous industry manufacturing and/or science experience
Responsibilities
  • Completing company training requirements in accordance with curricula and other training as may be required (e.g. completion of training when SOPs are updated or new SOPs issued that are applicable to production)
  • Ensure that the Master Batch Record is reviewed, the required batch record has been approved, and Quality issued prior to use and verify that the data, and information are correct, unambiguous, and clear for Production to run the batch.
  • Ensuring that released or stock is in “I” status and correct equipment is picked for production in accordance with the batch record prior to the commencement of production activity.
  • Organise workflow by ensuring required consumables, materials and equipment have been staged in time and staff assigned.
  • Maintains a clean and safe environment.
  • Enforce strict safety guidelines and company standards.
  • Assist with the on the job / competency training of new and existing Production Associates.
  • Reviewing executed production batch records and ensuring that these are completed and signed prior to forwarding to Quality for review and release.
  • Ensure all relevant transactions have been updated in the ERP system
  • Preparation and review of documentation as required including MBRs, SOPs, qualification/validation protocols, URS etc.
  • Participating in PCI internal audits and third-party audits and assist in responding to audit findings and product complaints/recalls as may be required
  • Assisting Clinical Projects and Customer Experience Team as required in preparing and reviewing MBRs, BRs, etc. prior to approval.
  • Assisting Storage and Distribution, Projects and Quality departments as required.
  • Assist in the capture of data and metrics of production processes and report them as required.
  • Raise EVENTS in MasterControl when issues are identified during Packaging & Labelling activity affecting product quality and patient safety.
  • Assist Production Associate Manager for investigation arising due to EVENT/DEV/NONC/COMP that occurs during production activity.
  • Review/perform checks as required during production activity and provides assistance and support to Production Associates to ensure right first time on batches and product quality.
  • Other duties as required by Manager/Head of Production.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PCI Pharma Services who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.